7D7X
 
 | |
7D7W
 
 | |
7D82
 
 | |
7D81
 
 | |
7D7Y
 
 | |
7D7V
 
 | |
7D7Z
 
 | |
2JXO
 
 | Structure of the second PDZ domain of NHERF-1 | 分子名称: | Ezrin-radixin-moesin-binding phosphoprotein 50 | 著者 | Cheng, H, Li, J, Dai, Z, Bu, Z, Roder, H. | 登録日 | 2007-11-27 | 公開日 | 2008-12-09 | 最終更新日 | 2024-05-29 | 実験手法 | SOLUTION NMR | 主引用文献 | Autoinhibitory Interactions between the PDZ2 and C-terminal Domains in the Scaffolding Protein NHERF1 Structure, 17, 2009
|
|
6EG5
 
 | The structure of SB-1-202-tubulin complex | 分子名称: | 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, 4-(2-chloropyrido[2,3-d]pyrimidin-4-yl)-7-methoxy-3,4-dihydroquinoxalin-2(1H)-one, CALCIUM ION, ... | 著者 | Banerjee, A.K, Wang, Y, Chen, H, Miller, D, Li, W. | 登録日 | 2018-08-18 | 公開日 | 2019-08-21 | 最終更新日 | 2023-10-11 | 実験手法 | X-RAY DIFFRACTION (2.45 Å) | 主引用文献 | The structure of SB-1-202/SB-2-204-tubulin complex To Be Published
|
|
4UY1
 
 | Novel pyrazole series of group X Secretory Phospholipase A2 (sPLA2-X) inhibitors | 分子名称: | 5-(2,5-DIMETHYL-3-THIENYL)-1H-PYRAZOLE-3-CARBOXAMIDE, CALCIUM ION, DI(HYDROXYETHYL)ETHER, ... | 著者 | Sandmark, J, Oster, L, Hallberg, K, Bodin, C, Chen, H. | 登録日 | 2014-08-28 | 公開日 | 2014-10-15 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Discovery of a Novel Pyrazole Series of Group X Secreted Phospholipase A2 Inhibitor (Spla2X) Via Fragment Based Virtual Screening Bioorg.Med.Chem.Lett., 24, 2014
|
|
7T6B
 
 | Structure of S1PR2-heterotrimeric G13 signaling complex | 分子名称: | (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, ... | 著者 | Li, X, Chen, H. | 登録日 | 2021-12-13 | 公開日 | 2022-04-06 | 最終更新日 | 2025-05-14 | 実験手法 | ELECTRON MICROSCOPY (3.19 Å) | 主引用文献 | Structure of S1PR2-heterotrimeric G 13 signaling complex. Sci Adv, 8, 2022
|
|
4TOR
 
 | Crystal structure of Tankyrase 1 with IWR-8 | 分子名称: | 1-[(1-acetyl-5-bromo-1H-indol-6-yl)sulfonyl]-N-ethyl-N-(3-methylphenyl)piperidine-4-carboxamide, CHLORIDE ION, Tankyrase-1, ... | 著者 | Chen, H, Zhang, X, Lum, L, Chen, C. | 登録日 | 2014-06-06 | 公開日 | 2015-05-20 | 最終更新日 | 2023-09-27 | 実験手法 | X-RAY DIFFRACTION (1.501 Å) | 主引用文献 | Disruption of Wnt/ beta-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells. Mol.Cell.Biol., 35, 2015
|
|
4TOS
 
 | Crystal structure of Tankyrase 1 with 355 | 分子名称: | Tankyrase-1, ZINC ION, trans-N-benzyl-4-({1-[(6-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yl)methyl]-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl}methyl)cyclohexanecarboxamide | 著者 | Chen, H, Zhang, X, Lum, l, Chen, C. | 登録日 | 2014-06-06 | 公開日 | 2015-05-20 | 最終更新日 | 2023-12-27 | 実験手法 | X-RAY DIFFRACTION (1.802 Å) | 主引用文献 | Disruption of Wnt/ beta-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells. Mol.Cell.Biol., 35, 2015
|
|
6LBC
 
 | shrimp ferritin-T158R | 分子名称: | FE (III) ION, Ferritin | 著者 | Zhao, G, Chen, H, Zhang, T. | 登録日 | 2019-11-14 | 公開日 | 2020-11-25 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (1.801 Å) | 主引用文献 | Construction of thermally robust and porous shrimp ferritin crystalline for molecular encapsulation through intermolecular arginine-arginine attractions. Food Chem, 349, 2021
|
|
6LBD
 
 | shrimp ferritin T158R G159R | 分子名称: | CHLORIDE ION, FE (III) ION, Ferritin | 著者 | Zhao, G, Chen, H. | 登録日 | 2019-11-14 | 公開日 | 2020-11-25 | 最終更新日 | 2023-11-22 | 実験手法 | X-RAY DIFFRACTION (1.386 Å) | 主引用文献 | Construction of thermally robust and porous shrimp ferritin crystalline for molecular encapsulation through intermolecular arginine-arginine attractions. Food Chem, 349, 2021
|
|
6W36
 
 | Crystal structure of FAM46C | 分子名称: | SULFATE ION, Terminal nucleotidyltransferase 5C | 著者 | Shang, G.J, Zhang, X.W, Chen, H, Lu, D.F. | 登録日 | 2020-03-09 | 公開日 | 2020-05-06 | 最終更新日 | 2024-03-06 | 実験手法 | X-RAY DIFFRACTION (2.854 Å) | 主引用文献 | Structural and Functional Analyses of the FAM46C/Plk4 Complex. Structure, 28, 2020
|
|
3P2T
 
 | Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k) | 分子名称: | Leukocyte immunoglobulin-like receptor subfamily B member 4, SULFATE ION | 著者 | Chen, Y, Nam, G, Cheng, H, Zhang, J.H, Willcox, B.E, Gao, G.F. | 登録日 | 2010-10-04 | 公開日 | 2011-03-30 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (1.699 Å) | 主引用文献 | Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance J.Biol.Chem., 286, 2011
|
|
4IPX
 
 | Analyzing the visible conformational substates of the FK506 binding protein FKBP12 | 分子名称: | (4S)-2-METHYL-2,4-PENTANEDIOL, Peptidyl-prolyl cis-trans isomerase FKBP1A | 著者 | Chen, H, Mustafi, S.M, Li, H.M, LeMaster, D.M, Hernandez, G. | 登録日 | 2013-01-10 | 公開日 | 2013-06-05 | 最終更新日 | 2023-09-20 | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | 主引用文献 | Analysing the visible conformational substates of the FK506-binding protein FKBP12. Biochem.J., 453, 2013
|
|
5UHN
 
 | |
5UGX
 
 | |
5UGL
 
 | |
4J98
 
 | |
5UI0
 
 | |
6C3L
 
 | Crystal structure of BCL6 BTB domain with compound 15f | 分子名称: | B-cell lymphoma 6 protein, N-[2-(1H-indol-3-yl)ethyl]-N'-{3-[(4-methylpiperazin-1-yl)methyl]-1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-6-yl}thiourea | 著者 | Linhares, B, Cheng, H, Cierpicki, T, Xue, F. | 登録日 | 2018-01-10 | 公開日 | 2019-01-16 | 最終更新日 | 2023-10-04 | 実験手法 | X-RAY DIFFRACTION (1.46092153 Å) | 主引用文献 | Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design. J.Med.Chem., 61, 2018
|
|
4HVB
 
 | Catalytic unit of PI3Kg in complex with PI3K/mTOR dual inhibitor PF-04979064 | 分子名称: | 1-{1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl}-3-methyl-8-(6-methylpyridin-3-yl)-1,3-dihydro-2H-imidazo[4,5-c][1,5]naphthyridin-2-one, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 著者 | Knighton, D.R, Cheng, H. | 登録日 | 2012-11-05 | 公開日 | 2013-11-20 | 最終更新日 | 2024-02-28 | 実験手法 | X-RAY DIFFRACTION (2.35 Å) | 主引用文献 | Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design. ACS Med Chem Lett, 4, 2013
|
|